Insider Transactions

What Indivior Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	2	10
Sells	3	3
Total trades	7	48

Shares traded

	3 months	12 months
Acquired	1,269,903	1,863,841
Disposed	685,721	870,072
Net activity	+584,182	+993,769

Common stock only — 5 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Anderson Woodrow D	Chief Accounting Officer	Aug 27	Open-market buy · P	+1,500	$35.69	+$53.5K	27,638
Anderson Woodrow D	Chief Accounting Officer	Aug 05	Open-market buy · P	+1,500	$36.28	+$54.4K	26,138
Heidbreder Christian	Chief Scientific Officer	Jul 10	Open-market sale · S	−18,586	$41.14	−$765K	209,337
Ciaffoni Joseph	Chief Executive Officer	Jun 22	Withheld — tax / exercise cost · F	−612,549	$38.32	−$23.5M	790,330
Ciaffoni Joseph	Chief Executive Officer	Jun 22	Exercise / conversion · M	+1,266,903	—	—	1,402,879
Heidbreder Christian	Chief Scientific Officer	Jun 11	Open-market sale · S	−18,586	$38.06	−$707K	227,923
Preblick Ryan	Chief Financial Officer	Jun 08	Open-market sale · S	−36,000	$37.70	−$1.36M	284,751
Ninivaggi Daniel A	Director	May 13	Grant / award · A	+6,518	—	—	27,163
Kingsley Stuart A	Director	May 13	Grant / award · A	+6,518	—	—	12,100
Stejbach Mark	Director	May 13	Grant / award · A	+6,518	—	—	27,087
Thompson Juliet	Director	May 13	Grant / award · A	+6,518	—	—	12,973
Wheadon David E.	Director	May 13	Grant / award · A	+10,430	—	—	30,780
Ryan Barbara	Director	May 13	Grant / award · A	+6,518	—	—	12,242
Humphreys Keith	Director	May 13	Grant / award · A	+6,518	—	—	16,042
Thompson Juliet	Director	May 12	Withheld — tax / exercise cost · F	−1,117	$38.28	−$42.8K	6,455
Preblick Ryan	Chief Financial Officer	Mar 14	Withheld — tax / exercise cost · F	−2,843	$31.11	−$88.4K	320,751
Preblick Ryan	Chief Financial Officer	Mar 14	Exercise / conversion · M	+6,302	—	—	323,594
Ryan Barbara	Director	Mar 13	Open-market buy · P	+8	$31.09	+$249	5,724
Ryan Barbara	Director	Mar 09	Open-market buy · P	+31	$32.56	+$1.01K	5,716
Kingsley Stuart A	Director	Mar 06	Open-market buy · P	+940	$31.87	+$30K	5,582

Page 1 of 3 · showing the 20 most recent Sign up free to view all 48 transactions and filter by insider →